Eugene Braunwald, Pioneering Cardiologist Who Shaped Modern Heart Medicine, Dies at 96

Eugene Braunwald, a pioneering cardiologist whose research transformed heart disease from a near-certain killer into a manageable condition, died on April 22, 2026, at the age of 96 in Newton, Massachusetts.

Braunwald, an Austrian-born American physician, was widely recognized as the father of modern cardiology for his groundbreaking contributions to the understanding and treatment of cardiovascular disease. His death was confirmed by Mass General Brigham, the parent organization of Brigham and Women’s Hospital in Boston, where he most recently served as Chief Academic Officer.

Born in Vienna in 1929 to Jewish parents, Braunwald fled the Nazi occupation as a child and immigrated to the United States as a refugee—an experience he described as formative in shaping his work ethic and outlook. He earned his undergraduate and medical degrees from New York University and completed his residency in internal medicine at Johns Hopkins School of Medicine.

His career spanned eight decades, during which he held leadership roles at some of the nation’s most prestigious medical institutions. He served as Chief of Cardiology and Clinical Director of the National Heart, Lung and Blood Institute, founding Chair of Medicine at the University of California, San Diego, Chair of the Department of Medicine at Brigham and Women’s Hospital in Boston, and Distinguished Hersey Professor of Medicine at Harvard Medical School.

Braunwald’s early work with collaborator Andrew Morrow resulted in a seminal 1964 monograph published in Circulation that first identified hypertrophic cardiomyopathy as a distinct clinical entity. This research laid the foundation for modern understanding of the genetic heart condition, which affects approximately one in 500 people.

In 1984, he founded the Thrombolysis in Myocardial Infarction (TIMI) Study Group, which revolutionized cardiovascular clinical trials by establishing large-scale, rigorous methodologies for evaluating treatments for heart attacks. The TIMI framework remains a cornerstone of cardiovascular research worldwide.

As founding editor of Braunwald’s Heart Disease—now in its eleventh edition—and a long-time editor of Harrison’s Principles of Internal Medicine, Braunwald shaped medical education for generations of physicians. His textbooks became standard references in cardiology and internal medicine training programs across the globe.

Colleagues remembered him not only for his scientific rigor but for his mentorship and insistence on deep, persistent inquiry. Thomas Lee, MD, who wrote Braunwald’s biography, noted that the cardiologist taught others to “focus on a problem and never let go of it,” emphasizing that true excellence meant going beyond publications and grants to pursue meaningful, lasting contributions to patient care.

Throughout his life, Braunwald received numerous honors, including the American College of Cardiology Distinguished Scientist Award in 1986. He was a longtime member and leader within the organization, which cited his work in hypertrophic cardiomyopathy and other specialties as central to his legacy as a transformative figure in cardiovascular medicine.

He is survived by his second wife, Elaine Smith, whom he married in 1994, and three children from his first marriage to Nina Starr, a thoracic surgeon and medical researcher who died in 1992. His passing marks the end of an era in cardiology, but his influence continues to guide research, clinical practice, and medical education worldwide.